KBLB (Kraig Biocraft Laboratories) Other Current Liabilities: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KBLB Kraig Biocraft Laboratories Inc KBLB
30 GF Score
Price $0.10
! 2 Warning Signs
View Full Analysis

What is Kraig Biocraft Laboratories Other Current Liabilities?

Kraig Biocraft Laboratories KBLB -0.34% 30 Other Current Liabilities is $0.00 Mil as of Mar. 2026. GuruFocus rates KBLB with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Kraig Biocraft Laboratories's other current liabilities for the quarter that ended in Mar. 2026 was $0.00 Mil.

Kraig Biocraft Laboratories's quarterly other current liabilities declined from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.00 Mil).

Kraig Biocraft Laboratories Other Current Liabilities Related Terms

Kraig Biocraft Laboratories Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Kraig Biocraft Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kraig Biocraft Laboratories Other Current Liabilities Chart

Kraig Biocraft Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kraig Biocraft Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00
KBLB
30GF Score
Kraig Biocraft Laboratories Inc KBLB
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kraig Biocraft Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.00 Mil mean?
Kraig Biocraft Laboratories (KBLB) has a Other Current Liabilities of $0.00 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Kraig Biocraft Laboratories.
Is Kraig Biocraft Laboratories' Other Current Liabilities too high?
Kraig Biocraft Laboratories' current Other Current Liabilities is $0.00 Mil. Overall, Kraig Biocraft Laboratories has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Kraig Biocraft Laboratories' Other Current Liabilities compare to AMTX and FSI?
Kraig Biocraft Laboratories' Other Current Liabilities of $0.00 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Chemicals company?
A good Other Current Liabilities depends on the Chemicals industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Kraig Biocraft Laboratories. Kraig Biocraft Laboratories's current Other Current Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kraig Biocraft Laboratories stock overvalued right now?
Kraig Biocraft Laboratories (KBLB) has a current Other Current Liabilities of $0.00 Mil. The current Other Current Liabilities is $0.00 Mil. Kraig Biocraft Laboratories' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Kraig Biocraft Laboratories (KBLB), the current Other Current Liabilities is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kraig Biocraft Laboratories Business Description

Address 2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.
30GF Score

Get the complete analysis for KBLB

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price